Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national
3
×
national blog main
national top stories
new york blog main
san francisco blog main
startups
3
×
venture capital
alnylam pharmaceuticals
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
What
medicines
3
×
bio
covid
ipo
roundup
acquisitions
activity
announced
approvals
aren’t
biogen
car
ceo
clamped
collabs
cutting
daniel
deal
delays
developing
economic
edge
experiments
fast
fda
gene
gilead
gilead’s
help
hot
including
interference
introduce
isn’t
launch
lot
market
month
new
oric’s
Language
unset
Current search:
national
×
startups
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”